Signal Advance, Inc., (OTC: SIGL) a leader in advanced signal processing and encryption solutions, has reached a major milestone with the United States Patent and Trademark Office issuing its first patent for the proprietary Analog Guard® technology—a breakthrough analog encryption method designed to deliver enhanced data protection by leveraging real-time signal transformation rather than traditional digital cryptographic algorithms and to enhance cybersecurity while significantly reducing the risk of remote hacking.

Analog Guard® is set to revolutionize secure communications, financial transactions, and military-grade encryption by providing an interference-resistant solution that bypasses common vulnerabilities found in digital systems. This innovation not only underscores Signal Advance’s commitment to pioneering new standards in encryption technology but also positions the company for expanded commercial and governmental applications in an era of heightened cyber threats.

Tech Companies to Watch:

• Moleculin Biotech, Inc. (NASDAQ: MBRX) is advancing its Phase 3 pipeline for hard-to-treat tumors and viruses with its lead candidate, Annamycin—a next-generation anthracycline designed to bypass multidrug resistance and eliminate cardiotoxicity for relapsed/refractory acute myeloid leukemia and soft tissue sarcoma lung metastases.
• GT Biopharma, Inc. (NASDAQ: GTBP), focusing on immuno-oncology therapies through its proprietary TriKE® NK cell engager platform licensed exclusively from the University of Minnesota, recently withdrew its S-1 Registration as it refines its development strategy.
• SKYX Platforms Corp. (NASDAQ: SKYX), known for its disruptive smart home technology and an impressive portfolio of over 97 patents and 60+ lighting and home décor websites, is collaborating with prefabricated home leader Cavco Industries, Inc. to integrate its advanced plug-and-play solutions into premium home models at the International Builders’ Show in Las Vegas from February 25-27, 2025.
• Banzai International (NASDAQ: BNZI) has launched CreateStudio 4.0, an upgrade to its award-winning video creation app by Vidello, now featuring advanced A.I. builders, hook generators, an A.I. assistant, enhanced audio visualizer, call-to-action tools, and a streamlined UI to further cement its reputation for producing eye-catching 3D character animations for social media and websites.
• CS Diagnostics Corp. (OTCQB: CSDX) – Launching Next-Generation Disinfection and Cancer Treatment Innovations CS Protect-Hydrogel, a breakthrough tissue spacer for radiation therapy, positioning itself at the forefront of healthcare technology. Also introduced MEDUSA, a smart disinfectant offering 10-day surface protection.

The issuance of this patent, coupled with Signal Advance’s proactive IP expansion strategy, reinforces its leadership in the emerging field of analog encryption and paves the way for accelerated commercialization. For more details, visit the official OTC Markets Report.

About Signal Advance, Inc.Signal Advance, Inc. specializes in advanced signal processing technologies that enhance encryption, cybersecurity, and secure communications for both governmental and private sector applications. Its Analog Guard® technology represents a significant leap forward in secure communications, setting the stage for future growth and market expansion in the high-security encryption industry.

Disclaimers: The Private Securities Litigation Reform Act of 1995 provides investors with a safe harbor with regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, assumptions, objectives, goals, and assumptions about future events or performance are not statements of historical fact and may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements, indicating certain actions & quotes; may, could or might occur Understand there is no guarantee past performance is indicative of future results. Investing in micro-cap or growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor’s investment may be lost or due to the speculative nature of the companies profiled. TheStreetReports (TSR) is responsible for the production and distribution of this content.”TSR” is not operated by a licensed broker, a dealer, or a registered investment advisor. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. “TSR” authors, contributors, or its agents, may be compensated for preparing research, video graphics, podcasts and editorial content. “TSR” has not been compensated to produce content related to “Any Companies” appearing herein. As part of that content, readers, subscribers, and everyone viewing this content are expected to read the full disclaimer in our website.

Media Contact
Company Name: The Street Reports
Contact Person: Editor
Email: Send Email
Country: United States
Website: http://www.thestreetreports.com